We would like to ensure that you are still receiving content that you find useful – please confirm that you would like to continue to receive ILO newsletters.
14 March 2018
Health Canada previously announced January 1 2018 as the proposed date for mandatory filing of specified regulatory activity. On January 12 2018 Health Canada published the Updated: Notice – Mandatory use of the Electronic Common Technical Document (eCTD) format, which served as confirmation of that date.
All new drug submission, supplementary new drug submission, abbreviated new drug submission and supplemental abbreviated new drug submission regulatory activities for human drugs – as well as additional information and subsequent regulatory activities and transactions – must be filed in eCTD format as of January 1 2018.
Exemption requests must be submitted and will be considered on a case-by-case basis.
For further information on this topic please contact Katie Lee at Smart & Biggar/Fetherstonhaugh by telephone (+1 416 593 5514) or email (email@example.com). The Smart & Biggar/Fetherstonhaugh website can be accessed at www.smart-biggar.ca.
The materials contained on this website are for general information purposes only and are subject to the disclaimer.
ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.